Investors

Committed to growth and innovation

Vytrus Biotech is a biotechnology company that develops cosmetic active ingredients from plant stem cell technology at industrial scale.

The firm is located in Terrassa (Barcelona, Spain) and commercializes its products in more than 50 countries around the world through its network of international distributors.
ACCESS TO CORPORATE WEBSITE

Share information

This section will provide the reader with further details in the coming weeks.

ACCESS TO BME Growth WEBSITE

Financial data

Find and download Vytrus Biotech financial information

Key documents

Revisión limitada de auditoría Vytrus primer semestre 2022

20/10/2022

PDF

Informe de auditoría de Vytrus 2021

25/04/2022

PDF

Revisión limitada 2021

31/08/2021

PDF

Informe de auditoría de Vytrus 2020

10/05/2021

PDF

Informe de auditoría de Vytrus 2019

11/05/2020

PDF

Press room

Read latest news about Vytrus Biotech:

26/01/2023

Vytrus Biotech receives valuation of 26.4 million euros according to GVC Gaesco

The biotechnology company has received a valuation report from GVC Gaesco Valores, which estimates a target price of 3.71€/share December 2023e for the company, equivalent to 26.4 million euros, 10% more than yesterday's closing price.

PDF

03/01/2023

Vytrus registers its first patent in Europe, USA and Japan for hair loss

Europe, USA and Japan have granted the Spanish stock market-listed company with a patent in the field of hair loss prevention and treatment, framed within the proprietary firm’s biotechnology platform called Phyto-Peptidic Fractions. Through this platform, Vytrus has developed several active ingredients from plant stem cells for applications in skincare and haircare.

PDF